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Abstract 17 
Bioactive peptides content in foodstuffs can seriously vary with many factors such as 18 
crop variety, food processing, animal breeding, etc. Because of this variability, quantitative 19 
methodologies are required to evaluate the content of bioactive peptides in foodstuffs. 20 
Progress in liquid chromatography and mass spectrometry technologies offer a great 21 
opportunity for the quantitation of bioactive peptides. This study undertook the development 22 
of a liquid chromatography-electrospray ionization-time of flight mass spectrometry method 23 
using a fused-core technology column for the sensitive and unambiguous determination of the 24 
immunostimulating peptide soymetide in soybean varieties. Soymetide precursor protein (α' 25 
subunit of β-conglycinin) was extracted with a Tris-HCl buffer (pH 8.0) containing urea and 26 
digested with trypsin. Soymetide separation conditions by reversed phase liquid 27 
chromatography (ion-pairing reagent, organic modifier, separation column, and elution 28 
gradient) and detection by MS were optimized and a study of soymetide stability was also 29 
conducted. Having demonstrated method selectivity, the linearity, accuracy, precision, and 30 
limits of detection and quantitation were evaluated. The developed method enabled the 31 
detection and quantitation of soymetide concentrations in the ppb range (7.5 ng/mL and 25 32 
ng/mL, respectively), and about 30 times lower than those detected and determined in a 33 
previous work by capillary liquid chromatography with UV detection. These values could 34 
allow the quantitation of only 17 µg of soymetide per gram of soybean. The developed 35 
methodology was applied to the quantitation of soymetide in different soybean varieties from 36 
Europe, Japan, and USA observing great differences in soymetide content that ranged from 40 37 
to 600 µg per gram of soybean depending on the soybean variety.  38 
 39 
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Introduction 42 
Functional foods containing bioactive peptides or proteins are nowadays a very 43 
interesting area of research. Many efforts are now focused on the exploration of new 44 
functional proteins and peptides in foods and on the design of functional foods containing 45 
these bioactive ingredients.1-4 Nevertheless, the number of works devoted to the quantitative 46 
determination of functional proteins or peptides is very low despite their content can 47 
significantly vary with many factors such as crop variety, food processing, animal breeding, 48 
etc. 49 
Quantitative determination of a peptide encrypted in a precursor protein requires 50 
seriously considering the treatment of the sample.5-7 In addition to the initial extraction of the 51 
parent protein, peptides inside a precursor protein need to be previously released, usually by 52 
enzymatic digestion of the parent protein.5-8 This digestion normally yields a highly complex 53 
extract containing up to hundreds of different peptides at different concentration levels.9-11 54 
The quantitation of a target peptide in this complex mixture requires its suitable separation 55 
and detection. Progresses in liquid chromatography (LC) and mass spectrometry (MS) 56 
technologies offer a great opportunity for this purpose.9-12  57 
LC column developments have been focused on accelerating chromatographic 58 
separations and to increase efficiency and sensitivity. Fused-core stationary phases consisting 59 
of superficially porous particles have attracted much attention in this regard.13-16 Generally, 60 
these particles consist of a solid core (between 1.7 and 3.3 µm) surrounded by a small porous 61 
shell (between 0.5 and 0.6 µm). Compared to totally porous particles, fused-core particles 62 
exhibit high column efficiency due to shorter diffusion paths which reduces mass transfer 63 
resistance and minimizes peak broadening. These features in addition to a very tight particle 64 
size distribution and a high packing density, result in columns with comparable efficiency to 65 
sub-2 µm particle columns and nearly twice the efficiency obtained with 3 µm particle 66 
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columns.17-19 An additional advantage of fused-core columns is that, unlike sub-2 µm particle 67 
columns, they do not require special instrumentation to cope with high backpressures. 68 
Soybean (Glycine max. (L.) Merr.) is a highly valuable legume and constitutes a cheap 69 
source of proteins (40-50%). Different bioactive proteins and peptides have been discovered 70 
in soybean such as the well-known lunasin. Another singular peptide in soybean is soymetide 71 
with a sequence of 13 amino acids (MITLAIPVNKPGR). Soymetide is the only food peptide 72 
exhibiting immunostimulating properties. This peptide is encrypted between the residues 173-73 
185 of the α´ subunit of 7S globulin (β-conglycinin).20-22 Therefore, unlike lunasin and other 74 
bioactive peptides, soymetide only shows immunostimulating activity when it is released 75 
from its parent protein by trypsin digestion.23,24 Released soymetide exhibits affinity for the 76 
N-formyl-methionyl-leucyl-phenylalanine (fMLP) chemotactic receptor 
 
presents on the 77 
neutrophils and macrophages surface. Since soymetide is a fMLP receptor agonist, a dietary 78 
ingestion of soybeans can send to the immune system signals similar to a bacterial infection, 79 
stimulating and strengthening it. This fact seems to contribute to a rapid response to bacterial 80 
infection, leading to bacterial death by phagocytosis and ROS-induced bactericidal effects.25 81 
Although different works have demonstrated soymetide capabilities, not much attention has 82 
been focused on the determination of this peptide in soybean and derived products. Indeed, 83 
only a previous work developed by our research team has determined this peptide in soybean 84 
dairy-like products (powdered milks and infant formulas). In that case, a capillary-high 85 
performance liquid chromatography method using UV detection was employed.21 Despite the 86 
interest of this first quantitative approach, lower detection and quantitation limits would 87 
enable a further knowledge on soymetide contents in other samples. Moreover, the study of 88 
the effect of the soybean genotype on the soymetide content would also be of great interest to 89 
select those varieties yielding higher soymetide content. These varieties would be preferred 90 
for the isolation of soymetide for the manufacture of functional foods and nutraceuticals.  91 
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The aim of this work was to develop a selective and sensitive analytical methodology 92 
enabling the determination of the bioactive peptide soymetide in different soybean varieties 93 
by liquid chromatography-electrospray ionization-time of flight (LC-ESI-TOF) mass 94 
spectrometry (MS) using a fused-core technology column. 95 
 96 
 Materials and methods 97 
 98 
Chemicals and samples 99 
Acetonitrile, methanol,
 
trifluoroacetic acid, and acetic acid of HPLC grade (Sigma, St. 100 
Louis,USA) were used for the preparation of mobile phases. Calcium chloride was from 101 
Panreac (Barcelona, Spain). Hydrochloric and formic acids, hydroxymethylaminomethane 102 
(Tris), and urea were from Merck (Darmstadt, Germany). Dithiothreitol, iodoacetamide, 103 
bovine serum albumin, and trypsin type IX-S from bovine pancreas were from Sigma. Nine 104 
different soybean varieties [Fred (France), Flora (France), Zolta Przebedowska (Poland), 105 
Tokachi (Japan), Tokachi Napaha (Japan), Nagaha-jiro (Japan), Mrit (USA), Harosoy 63 106 
(USA), and Evans (USA)] were from the germplasm collection of the CRF-INIA (Centro de 107 
Recursos Fitogenéticos del Instituto Nacional de Investigaciones Agrarias, Madrid, Spain). A 108 
soybean protein isolate (SPI) with a protein content of 89.1% (determined by Kjeldahl 109 
analysis) was from ICN (Aurora, OH, USA). Soymetide-13 standard was synthesized by SBS 110 
Genetech (Beijing, China). All solutions were prepared with ultrapure water from a Milli-Q 111 
system (Millipore, Bedford, MA, USA).  112 
 113 
Protein extraction and digestion 114 
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Soybeans were ground using a domestic miller followed by partial moisture removal 115 
in a thermostated oven for 3 h at 50 °C. Ground soybeans were sieved using different mesh 116 
sizes to obtain particle sizes ranging 0.05 – 0.6 mm.  117 
Extraction of soybean proteins was carried out using a method previously described.21 118 
For that purpose, 180 mg of grounded soybean were dissolved in 3 mL of 50 mM Tris–HCl 119 
buffer at pH 8.0 containing 8 M urea. After sonication for 3 min, samples were centrifuged 120 
for 7 min at 4000 g. The supernatant fraction was collected for its enzymatic digestion. 121 
Protein digestion was performed following a procedure described previously.26 The 122 
procedure consisted of treating 1 mL of protein extract with 100 µL of 50 mM dithiothreitol 123 
for 20 min at 50 ºC. After cooling to room temperature, alkylation of free thiol groups was 124 
performed by the addition of 110 µL of 100 mM iodoacetamide for 5 min. The resulting 125 
solution was diluted 10 times in 11 mM CaCl2 (in 50 mM Tris–HCl at pH 8.0) in order to 126 
reduce the final urea concentration. Digestion was performed by adding 20 µL of 1 mg/mL 127 
trypsin solution to the diluted sample for 12 h at 37 ºC. Finally, the digestion reaction was 128 
stopped by adding 50 µL of trifluoroacetic acid and final solutions were filtered through 0.45 129 
µm pore size regenerated cellulose Titan 2 filter membranes (MicroSolv Technology Corp., 130 
Eatontown, NJ, USA) prior to injection into the LC system.  131 
 132 
LC separation 133 
A 1100 series LC (Agilent Technologies, Palo Alto, CA, USA) equipped with a diode-134 
array detector, an automatic injector, a quaternary pump, and a thermostatic column 135 
compartment was employed. Preliminary experiments were performed with a 100 mm x 2.1 136 
mm i.d., 10 µm, POROS R2/10 perfusion column (Perseptive Biosystems, Framingham, MA, 137 
USA). For that purpose, acetic acid and formic acid
 
at three concentrations (0.1, 0.3, and 138 
0.5%) and two different organic modifiers (acetonitrile or methanol) were employed with the 139 
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following gradient: 5-30% B in 10 min, 30-95% B in 3 min, 95% B for 5 min to clean the 140 
column, 95-5% B in 1 min, and 5% B for 5 min for the re-equilibration of the column at the 141 
initial conditions; mobile-phase, water-organic modifier containing an ion-pairing reagent; 142 
flow-rate, 0.5 mL/min; injected volume, 3 µL; temperature, 50 ºC. Final quantitation was 143 
carried out with a 100 mm x 2.1 mm i.d., 2.7 µm, Ascentis Express Fused-Core peptide ES-144 
C18 column with a 5 mm x 2.1 mm i.d. peptide ESC18 Ascentis Express guard column of the 145 
same material (Sigma,
 
St. Louis, USA). The optimized conditions with this column were: 146 
flow-rate, 0.5 mL/min; mobile phases, 0.3% (v/v) acetic acid in water (phase A) and 0.3% 147 
(v/v) acetic acid in acetonitrile (phase B); binary gradient, 15-20% B in 4 min, 20-95% B in 3 148 
min, 95% for 5 min to clean the column, 95-15% B in 1 min, and 15% B for 5 min for the re-149 
equilibration of the column at the initial conditions; injected volume, 3 µL; temperature, 50 150 
ºC. The dead volume of the system was equivalent to 0.5 min and the delay time in the 151 
gradient was 2.6 min.  152 
In order to ensure the identity of soymetide, hydrolysates and spiked hydrolysates 153 
were injected and compared. 154 
 155 
MS detection 156 
MS detection was performed in a Quadrupole Time-of-Flight (Q-TOF) series 6530 157 
(Agilent Technologies, Palo Alto, CA, USA) equipped with an Agilent Mass Hunter software 158 
that was used for MS control, data acquisition, and data analysis. Optimized ESI parameters 159 
were: capillary voltage, 3500 V; nozzle voltage, 1500 V; drying gas conditions, 10 L/min and 160 
350 ºC; nebulizer pressure, 2.7 bar; sheath gas conditions, 12 L/min and 400 ºC. Other 161 
optimized MS parameters were: fragmentator, 150 V; skimmer, 60 V; octapole voltage, 750 162 
V. Spectra were acquired in the positive ion mode at 2 GHz over the range m/z
 
100-1700 163 
(extended dynamic range)
 
with an acquisition rate of 2 spectra/s. Purine with an [M+H]+ ion 164 
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at m/z 121.0509 and an Agilent compound (HP0921) yielding an ion at m/z 922.0098 were 165 
simultaneously introduced, and used as internal standards throughout the analysis. 166 
 167 
Data treatment 168 
Soymetide identification and amino acid sequencing were carried out from the MS/MS 169 
spectra using Mascot database.  170 
Detection and quantitation was performed from the extracted ion chromatogram (EIC) 171 
obtained by the extraction of signals from the most intense isotopic peak of the (M+2H)+2 and 172 
(M+3H)+3 ions of soymetide (m/z 470.6171 and m/z 705.4206) using as extraction window ± 173 
25 ppm.  174 
Signal-to-noise (S/N) ratio was calculated by Mass Hunter MS software establishing 175 
the peak height as the signal and the noise as five times the standard deviation of the 176 
background. Detection (LOD) and quantitation (LOQ) limits were calculated as the 177 
concentration yielding a S/N ratio of 3 and 10, respectively. 178 
 179 
 Results and discussion 180 
 181 
LC/MS method development 182 
A previous research work of our group described the separation of soymetide from a 183 
tryptic soybean digestion extract using micro-LC and UV detection.21 
 
Experimental 184 
conditions selected in that case consisted of a mobile phase containing trifluoroacetic acid as 185 
ion-pairing reagent. Since trifluoroacetic acid is a known strong signal suppressor in MS,27 186 
some preliminary experiments using other ion-pairing reagents were firstly conducted to 187 
select separation conditions that were compatible with MS detection. Different mobile phases 188 
used in reversed phase LC/MS were optimized based on the sensitivity of the soymetide 189 
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standard peak, estimated from the S/N ratio in the EIC, and the percentage of mobile phase B 190 
at which soymetide eluted (see in supporting information). For that purpose, mobile phases 191 
containing acetic acid or formic acid as ion-pairing reagents at three different concentrations 192 
(0.1, 0.3, and 0.5 %) and with two different organic modifiers (acetonitrile or methanol) were 193 
employed. A 0.3% (v/v) acetic acid solution in acetonitrile yielded the highest sensitivity and 194 
recovery. These conditions were suitable to observe the mass spectrum of the soymetide 195 
standard shown in Figure 1. The two highest peaks corresponded to ions (M+3H)+3 (m/z 196 
470.6171) and (M+2H)+2 (m/z 705.4206). Moreover, a tiny signal attributed to ion MH+ (m/z 197 
1409.8284) was also observed. In addition, the isotopic clusters of the ions (M+3H)+3 and 198 
(M+2H)+2 showed that the highest peaks corresponded to the smaller m/z values.  199 
Secondly, optimization of ESI parameters was carried out to obtain the best S/N 200 
values. For that purpose, a digested extract of SPI was employed. The studied range for 201 
parameters that exclusively depended on mobile phase flow-rate and composition were: 202 
nebulizer pressure (2.0-3.5 bar),
 
drying gas flow-rate (8-12 L/min), sheath gas flow-rate (6.5-203 
12 L/min), and capillary voltage (3000-4000 V). Other studied parameters also depending on 204 
mobile phase flow-rate and composition but limited by analyte thermal stability were: drying 205 
gas temperature (250-350 ºC) and sheath gas temperature (300-400 ºC). The optimized ESI 206 
parameters obtained with the previously selected mobile-phase composition and a flow-rate of 207 
0.5 mL/min were: nebulizer pressure, 2.7 bar; drying gas flow-rate, 10 L/min; sheath gas 208 
flow-rate, 12 L/min; capillary voltage, 3500 V; drying gas temperature, 350 ºC, and sheath 209 
gas temperature, 400 ºC.
 
Finally, ESI parameters only depending on analyte were also studied: 210 
nozzle voltage (0-2000 V) and fragmentator voltage (100-200 V). Optimal nozzle and 211 
fragmentator voltages were 1500 and 150 V, respectively. Skimmer and octapole voltages 212 
were automatically tuned by the instrument and their values were 60 V and 750 V, 213 
respectively.  214 
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Extracted Compounds Chromatograms (ECC) obtained by Mass Hunter MS software 215 
show all co-eluting compounds found using a deconvolution process by molecular features. 216 
Figure 2A shows the ECC
 
and spectrum obtained for the retention time of soymetide with the 217 
optimized LC/MS conditions when a digested extract of SPI was employed
 
to verify the 218 
chromatographic separation. As observed in the spectrum, there are two main ions (m/z 219 
464.6309 and m/z 696.4416) in addition to the two ions of soymetide (m/z 470.6167 and m/z 220 
705.4206). These two new signals corresponded to a compound with a molecular mass 18 221 
units lower than soymetide (MITLAIPVNKPGR). MS/MS experiments attributed these 222 
signals to a peptide with an amino acidic sequence (LITLAIPVNKPGR) differing in just one 223 
aminoacid (leucine) with a molecular mass 18 Da lower than methionine. In order to avoid 224 
these coelutions, another column with different selectivity and higher efficiency than the 225 
perfusion column was tested.  Figure 2B shows how the use of a new fused-core column 226 
enabled the separation of soymetide from the peptide
 
with 18 Da lower molecular mass and 227 
yielded narrower chromatographic peaks. However, the new spectrum obtained along the 228 
elution peak of soymetide showed additional smaller ions also co-eluting with soymetide. In 229 
order to improve the selectivity in the separation of soymetide, the elution gradient was 230 
optimized. Figure 2C shows how the optimization of the gradient (15-20 % B in 4 min), 231 
enabled the separation of soymetide with enough selectivity, there being only a small co-232 
elution with another compound whose ions (m/z 488.5936 and m/z 732.3827) were 233 
significantly different from those of soymetide. 234 
In order to select an optimum extraction window for maximum selectivity while 235 
preserving sensitivity and chromatographic fidelity in the quantitation of soymetide, different 236 
extracting widths of ions used as quantifiers in the EICs were tested. According to Figure 1, 237 
the highest peak in the (M+3H)+3 isotopic cluster corresponded to m/z 470.6171 and in the 238 
(M+2H)+2 isotopic cluster corresponded to m/z 705.4206. These signals were used as 239 
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quantifier ions, their baseline widths being approximately 120 ppm. Narrower extracting 240 
windows were more selective and yielded higher S/N ratios (see in supporting information), 241 
but resulted in lower calibration slopes and worse determination coefficients (R2 < 0.9). 242 
Therefore, an extracting width of 50 ppm (± 25 ppm symmetric extraction window) was 243 
established as a good compromise between selectivity and sensitivity for the quantitation of 244 
soymetide. 245 
On the other hand, due to the narrower peaks using fused-core column, another 246 
important parameter to take into account in quantitative analysis is the data acquisition speed. 247 
Generally, 15 measurement cycles across a chromatographic peak are considered adequate for 248 
good peak precision (relative standard deviation [RSD] < 1%). Taking into account the 249 
selected scanned mass range (m/z 100-1700), a data acquisition speed of 2 spectra/s allowed 250 
18 cycles per peak which is enough for a suitable peak precision. Higher data acquisition 251 
speeds will lead a reduction in the accumulation time of transitions/spectra and, therefore, in a 252 
loss of sensitivity.  253 
Finally, we investigated the possibility of improving the sensitivity in the quantitation 254 
of soymetide using MS/MS experiments and ions m/z 470.6 and m/z 705.4 as precursors. For 255 
that purpose, a collision cell energy providing few but intense fragment ions while preserving  256 
10% of intact precursor ion was selected within the range 15-30 V. Since the best sensitivity 257 
obtained by MS/MS (energy at 17 V in collision cell) was less than that observed in the MS 258 
mode, the MS/MS experiments for the quantitation of soymetide was discarded due to the 259 
high chromatographic selectivity and best S/N in MS mode. 260 
 261 
Development and analytical characterization of the quantitative method 262 
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In the study of soybean sample, the results showed a decrease in soymetide signal 263 
when mesh sizes higher than 0.2 mm were employed. Therefore, a mesh size ranging from 264 
0.05 to 0.2 mm was selected. 265 
Moreover, a stability study of the soymetide standard (100 ng/mL prepared in an 266 
aqueous solution) and the digested soybean sample was carried out. For that purpose, 267 
standards and digested samples were kept at room temperature over the range 0-72 h. No 268 
significant difference was observed in the case of the digested soybean sample up to 72 h 269 
storage time. However, a significant loss of signal was observed in the case of the soymetide 270 
standard which was
 
attributed to its adsorption on the vial walls, regardless of the use of 271 
plastic or glass containers. In order to avoid this problem, different soluble media were tried: 272 
water, acetic acid (0.3%), Tris-HCl (pH 8.0), acetonitrile, and bovine serum albumin solutions 273 
(100 ng/mL and 1000 ng/mL). Best results were obtained using 0.3% (v/v) acetic acid in glass 274 
vials. Furthermore, three different storage temperatures were also tested (room temperature, 4 275 
ºC, and -22 ºC) observing no signal reduction when keeping the standards at least 24 h at 4 ºC 276 
or more than 72 h at -22 ºC.  277 
Once method selectivity was demonstrated, the following analytical characteristics 278 
were studied (see in supporting information): linearity, accuracy, precision, and LOD and 279 
LOQ. Linearity was assessed using six standard solutions in the range 25-1000 ng/mL and 280 
observing a good linear correlation (R2 = 0.9991). Moreover, intercept did not significantly 281 
differ from zero (P < 0.05). LOD and LOQ for soymetide were 7.5 ng/mL and 25 ng/mL, 282 
respectively. These values could allow the quantitation of 17 µg of soymetide per gram of 283 
soybean which indicates a reduction of more than 27 times in the limits of detection and 284 
quantitation previously obtained by our research group21.  Presence of matrix interferences 285 
was evaluated by comparing the slopes obtained by the external standard and the standard 286 
additions calibration methods, using three different soybeans varieties (Fred, Nagaha-jiro and 287 
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Harosoy 63, one of each geographic region). Results showed no significant differences 288 
between the slopes (with p-values between 0.2925 and 0.7238), confirming the absence of 289 
matrix interferences and allowing the use of the external standard calibration method for the 290 
quantitation of soymetide in soybean. The accuracy of the analytical method was assessed by 291 
evaluating the recovery of different amounts of added soymetide to a soybean sample in 292 
which soymetide was not detected observing recoveries very close to 100% as shown in 293 
Figure 3 (between 100.0% and 101.7% with a RSD ≤ 3.7%). Finally, precision was evaluated 294 
in terms of instrumental repeatability, and intermediate precision. Instrumental repeateability 295 
was obtained from six consecutive injections of soymetide standard solutions to LOD and 296 
LOQ levels and two soybean samples (Fred and Evans). RSD values lower than 3.0% for 297 
standard solutions and 4.2% for soybean samples were obtained. Intermediate precision was 298 
obtained by injecting three replicates during three consecutive days of soymetide standard 299 
solutions to LOD and LOQ levels and two soybean samples (Fred and Evans). RSD values 300 
lower than 4.1% for standard solutions and 6.6% for soybean samples were obtained.  301 
In summary, a LC-ESI-TOF method has been developed enabling the selective and 302 
sensitive determination of the immunostimulating peptide soymetide in soybeans in about 15 303 
min. The main advantage of this method over the previous one is that thanks to high 304 
resolution MS experiments, performed with the TOF analyzer, together with a fused-core 305 
technology column and a suitable method optimization have made possible the unambiguous 306 
identification and determination of soymetide in tryptic digestions of soybean. Also the new 307 
method presented good accuracy and precision and was able to quantitate 17 µg of soymetide 308 
per gram of soybean, which significantly improves the detection and quantitation limits 309 
previously obtained for soymetide. 310 
 311 
Soymetide quantitation in different soybeans varieties  312 
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The developed method was next applied to the determination of soymetide in different 313 
soybean varieties: three from Europe, three from Japan, and three from USA. As example, 314 
Figure 4 shows the signal obtained for a soybean sample. Despite sample complexity, the 315 
selectivity of the method was demonstrated in the EIC and in the spectrum corresponding to 316 
the soymetide peak. This method allowed the unequivocal determination of the 317 
immunostimulating peptide soymetide in soybeans and the re-equilibration of the column at 318 
the initial conditions in only 15 min. 319 
Results obtained, grouped in Table 1, show that soymetide concentrations ranged 320 
from 41.3 to 597 µg/g soybean with the exception of the Harosoy 63 variety, in which case, 321 
the signal was below the LOD. Great differences in soymetide contents were observed when 322 
the method was applied to the determination of soymetide in different soybean varieties. This 323 
demonstrated that not all soybean varieties showed the same immunostimulating activity or 324 
were equally suitable for subsequent use in the preparation of functional foods or 325 
nutraceuticals. No correlation between the soymetide content and the soybean geographical 326 
origin was observed. Nevertheless, it should be noted that growing conditions and soybean 327 
processing may affect these values. Since the concentration required for 50% of maximum 328 
phagocytotic activation (IC50) has been established in approximately 1 µM of soymetide in 329 
plasma, the ingestion of about 4 mg of soymetide would be necessary for an adult to reach 330 
this IC50 value.20 Taking into account this fact, the required consumption of soybean to obtain 331 
an immunostimulating effect is about 100 g for the soybean variety with the minimum 332 
soymetide content. However, currently there are no pharmacokinetic studies that can confirm 333 
these calculations. Moreover, soybean varieties Tokachi (Japan) and Flora (France) can be 334 
considered very suitable for the isolation of this bioactive peptide for the preparation of 335 
functional foods and nutraceuticals with immunostimulating activity. The method constitutes 336 
a very powerful tool to evaluate what soybean varieties and what growing conditions and 337 
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soybean processing would be most suitable for isolation of the bioactive peptide for the 338 
preparation of functional foods and nutraceuticals with immunostimulatory activity and could 339 
also be applied for pharmacokinetic studies to confirm the immunostimulatory activity of 340 
soymetide in soybeans.   341 
342 
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 Supporting Information Available: Description 352 
Figure S1 shows the effect of different mobile phases used in reversed phase LC/MS 353 
on the sensitivity of soymetide standard peak, estimated from the S/N ratio in the EIC, and the 354 
percentage of mobile phase B at which soymetide eluted.
  355 
Table S1 shows the relative slopes, square regression coefficient, and signal-to-noise 356 
ratio obtained with different extracting widths.
  357 
Table S2 shows the analytical characteristics of the optimized LC-ESI-TOF MS 358 
method for the determination of soymetide. 359 
 360 
361 
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Figure captions 438 
 439 
Figure 1. Mass spectrum corresponding to a soymetide standard with acetonitrile as organic 440 
modifier and 0.3% (v/v) acetic acid as ion-pairing reagent.  441 
 442 
Figure 2. Extracted compound chromatograms generated by deconvolution and mass spectra 443 
over elution time of soymetide corresponding to digested extract of SPI analyzed with 444 
different columns and gradients. (A) POROS R2/10 perfusion column; (B) Ascentis Express 445 
Fused-Core peptide ES-C18 column with the same gradient as in (A); (C) Ascentis Express 446 
Fused-Core peptide ES-C18 column with a new optimized gradient.  447 
 448 
Figure 3. Extracted ion chromatograms corresponding to two replicates (A and B) of a 449 
soybean sample without content in soymetide (Harosoy 63) spiked with soymetide standard 450 
(25 ng/mL), and two replicates (C and D) of a soymetide standard solution (25 ng/mL).  451 
Experimental conditions as Figure 2C. 452 
 453 
Figure 4. Chromatograms corresponding to a soybean sample (Fred) and the mass spectrum 454 
of soymetide peak under the optimized LC and MS conditions. (A) TIC; and (B) EIC 455 
corresponding to ions m/z 470.6169 and m/z 705.4191 using an extracted width of 50 ppm. 456 
Experimental conditions as Figure 2C.457 
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Table 1. Determination of Soymetide in Different Soybean Varieties by LC-ESI-TOF MS. 
 
 
 
Variety Country of 
origin 
soymetide/product a 
(µg/g; average ± s.d.) RSD %
 b
  
Soybean 
consumption to 
achieve soymetide 
IC50 c (g) 
Fred France 70.9 ± 3.9 5.6 63 
Flora France 428 ± 47 11 10 
Zolta 
Przebedowska Poland 92.1 ± 4.4 4.8 48 
Tokachi Japan 597 ± 59 10 7 
Tokachi 
Napaha Japan 358 ± 20 5.6 12 
Nagaha-jiro Japan 41.3 ± 2.4 6 108 
Merit USA 48.4 ± 4.7 10.2 92 
Harosoy 63 USA < LOD -- -- 
Evans USA 207 ± 13 6.6 21 
 
a Average values and standard deviations for three replicates of each bean extracted and 
digested each injected in triplicate. 
b
 RSD calculated with three replicates of each bean extracted and digested, injected in 
triplicate.  
c
 IC50: half maximal inhibitory concentration, 1 µM in plasma20. 
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